Most clinical trials in the Section of Cardiovascular Research are conducted in the Lipid Metabolism and Atherosclerosis Clinic. Eligible participants are essential to medical research and make important contributions to improving medical practice and human health. Individuals interested in participating are encouraged to call 713-798-5800 to determine eligibility.
New Studies Recruiting Participants
- ACCLAIM-Lp(a) Study for Patients with Elevated Lipoprotein(a) - (H-55126)
- OCEAN(a)-PreEvent Study for Patients with Elevated Lipoprotein(a) - (H-57595)
Ongoing Clinical Research Projects
- Lp(a)HORIZON Study for Patients with Elevated Lipoprotein(a) - (H-46928)
- OCEAN(a)-Outcomes Study for Patients with Elevated Lipoprotein(a) - (H-52305)
- SHASTA-3 Study for Patients with Severe Hypertriglyceridemia - (H-55277)
- MUIR-3 Study for Patients with Hypertriglyceridemia - (H-55278)
- ZEUS Study for Patients with Cardiovascular Disease, Chronic Kidney Disease and Inflammation - (H-50642)
- CORE Study for Patients with Severe Hypertriglyceridemia - (H-50667)
- BALANCE-OLE Study for Patients with Familial Chylomicronemia Syndrome - (H-50852)
- SHASTA-2 and MUIR Open-Label Extension Study for Patients with Dyslipidemia - (H-51839)
- CORALreef Extension Study for Patients with Hypercholesterolemia - (H-55325)
- CORE-OLE Open-label Extension Study for Patients with Severe Hypertriglyceridemia - (H-55664)






